FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable SuspensionEdvardas Kaminskas, Richard Pazdur, Ann T. Farrell et al.|The Oncologist|2005Cited by 488
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome SubtypesEdvardas Kaminskas, Richard Pazdur, Ann Farrell et al.|Clinical Cancer Research|2005Cited by 424
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR. Angelo de Claro, Richard Pazdur, Karen M. McGinn et al.|Clinical Cancer Research|2015Cited by 165